As per the GOI circular on price capping of Orthopaedic Knee implant by NPPA(National Pharmaceutical Pricing Authority), new prices of knee implants have been implemented effective 16th August 2017. For details on knee implant pricing across our hospitals. CLICK HERE | As per GOI’s circular dated 02nd April 2018 on price-capping of stents by NPPA(National Pharmaceutical Pricing Authority), new prices of coronary stents are revised with effect from 01st April, 2018. For details on stent pricing.CLICK HERE

Media Room

Fortis records uptick in consolidated India revenues and margins in FY16.

Date : May 26, 2016

Fortis Healthcare Ltd. (Fortis), India‟s leading healthcare delivery Company, today, announced its consolidated results for the quarter and year ended March 31, 2016 (Q4FY16 and FY16).

The Board of the Company has decided to assess and evaluate a demerger of the diagnostics business of the Company in addition to other options that may be available to unlock and monetize value inherent in this business. The same is subject to finalization by the Board and other stakeholders.

India Business - Key Financial Highlights for the year (FY16)

  • Consolidated India Business Revenues at Rs 4,213 Cr, up 7.3%.
  • Consolidated Operating EBITDAC for the India Business (EBITDA before net business trust costs) was at Rs 692 Cr, +14.2%, representing a margin of 16.4% versus 15.4% in the previous year.
  • Consolidated Operating EBITDA for the India Business was at Rs 235 Cr, up 46%, representing a margin of 5.6% versus a margin of 4.1% in the previous year.

For more information, please contact:
Fortis Healthcare:
Priya Bendre - 77385 70894

Read Complete Press Release on below link:

Download Pdf - English

PrintCopy TextGo Back